BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DRD2
,
Metabolism of xenobiotics
,
Leukemia
,
Leukocyte
,
Holistic medicine
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
metastatic adenocarcinoma of unknown primary site
Summary
General Info
Curated Studies
Most Correlated Studies
Gene expression profiles of poorly differentiated, moderately differentiated and metastatic cancers
Brain metastatic isolates compared to parental breast tumors in patient samples and MDA-MB-231 cells
Bone marrow of mice with prostate cancer cell line xenografts
Prostate cancer LNCaP cell line overexpressing miR-106b
Prostate cancer LNCaP cells treated with dihydrotestosterone (DHT) or methyltestosterone (MeT)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for metastatic adenocarcinoma of unknown primary site
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Prim…
Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ